Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$24.30 -0.80 (-3.17%)
Closing price 03:58 PM Eastern
Extended Trading
$24.10 -0.20 (-0.82%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

WRBY vs. GKOS, STVN, BLCO, LQDA, and LIVN

Should you buy Warby Parker stock or one of its competitors? MarketBeat compares Warby Parker with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Warby Parker include Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Liquidia (LQDA), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

How does Warby Parker compare to Glaukos?

Glaukos (NYSE:GKOS) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

Glaukos has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.96, meaning that its share price is 96% more volatile than the broader market.

Warby Parker has a net margin of 0.15% compared to Glaukos' net margin of -34.34%. Warby Parker's return on equity of 2.30% beat Glaukos' return on equity.

Company Net Margins Return on Equity Return on Assets
Glaukos-34.34% -6.92% -5.25%
Warby Parker 0.15%2.30%1.18%

Warby Parker has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Glaukos$507.44M13.11-$187.69M-$3.28N/A
Warby Parker$871.91M2.98$1.64M$0.021,214.75

In the previous week, Glaukos and Glaukos both had 3 articles in the media. Warby Parker's average media sentiment score of 0.98 beat Glaukos' score of 0.16 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Glaukos
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.0% of Glaukos shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 5.9% of Glaukos shares are held by insiders. Comparatively, 16.8% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Glaukos presently has a consensus target price of $146.17, indicating a potential upside of 28.99%. Warby Parker has a consensus target price of $29.50, indicating a potential upside of 21.42%. Given Glaukos' stronger consensus rating and higher probable upside, research analysts clearly believe Glaukos is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Glaukos
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.79
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.64

Summary

Warby Parker beats Glaukos on 10 of the 15 factors compared between the two stocks.

How does Warby Parker compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

In the previous week, Stevanato Group had 3 more articles in the media than Warby Parker. MarketBeat recorded 6 mentions for Stevanato Group and 3 mentions for Warby Parker. Warby Parker's average media sentiment score of 0.98 beat Stevanato Group's score of 0.80 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Warby Parker has a consensus price target of $29.50, suggesting a potential upside of 21.42%. Given Warby Parker's higher probable upside, analysts clearly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.64

93.2% of Warby Parker shares are held by institutional investors. 0.7% of Stevanato Group shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Stevanato Group has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.96, meaning that its stock price is 96% more volatile than the broader market.

Stevanato Group has a net margin of 11.76% compared to Warby Parker's net margin of 0.15%. Stevanato Group's return on equity of 10.27% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group11.76% 10.27% 6.08%
Warby Parker 0.15%2.30%1.18%

Stevanato Group has higher revenue and earnings than Warby Parker. Stevanato Group is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group€1.34B4.20€158.21M€0.5931.53
Warby Parker$871.91M2.98$1.64M$0.021,214.75

Summary

Stevanato Group beats Warby Parker on 10 of the 17 factors compared between the two stocks.

How does Warby Parker compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

In the previous week, Bausch + Lomb had 3 more articles in the media than Warby Parker. MarketBeat recorded 6 mentions for Bausch + Lomb and 3 mentions for Warby Parker. Warby Parker's average media sentiment score of 0.98 beat Bausch + Lomb's score of 0.60 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Bausch + Lomb currently has a consensus price target of $17.92, indicating a potential upside of 20.30%. Warby Parker has a consensus price target of $29.50, indicating a potential upside of 21.42%. Given Warby Parker's stronger consensus rating and higher probable upside, analysts clearly believe Warby Parker is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.21
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.64

Warby Parker has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch + Lomb$5.10B1.04-$360M-$0.62N/A
Warby Parker$871.91M2.98$1.64M$0.021,214.75

Bausch + Lomb has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.96, indicating that its share price is 96% more volatile than the broader market.

Warby Parker has a net margin of 0.15% compared to Bausch + Lomb's net margin of -4.21%. Bausch + Lomb's return on equity of 3.60% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch + Lomb-4.21% 3.60% 1.69%
Warby Parker 0.15%2.30%1.18%

Summary

Warby Parker beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

How does Warby Parker compare to Liquidia?

Liquidia (NASDAQ:LQDA) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

64.5% of Liquidia shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 25.6% of Liquidia shares are held by insiders. Comparatively, 16.8% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Liquidia has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market.

Liquidia has a net margin of 7.74% compared to Warby Parker's net margin of 0.15%. Liquidia's return on equity of 46.82% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Liquidia7.74% 46.82% 7.06%
Warby Parker 0.15%2.30%1.18%

In the previous week, Liquidia had 5 more articles in the media than Warby Parker. MarketBeat recorded 8 mentions for Liquidia and 3 mentions for Warby Parker. Warby Parker's average media sentiment score of 0.98 beat Liquidia's score of 0.75 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Liquidia
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Liquidia currently has a consensus price target of $50.88, suggesting a potential downside of 8.38%. Warby Parker has a consensus price target of $29.50, suggesting a potential upside of 21.42%. Given Warby Parker's higher probable upside, analysts plainly believe Warby Parker is more favorable than Liquidia.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Liquidia
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
3 Strong Buy rating(s)
2.91
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.64

Warby Parker has higher revenue and earnings than Liquidia. Liquidia is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liquidia$158.32M31.19-$68.92M$0.14396.64
Warby Parker$871.91M2.98$1.64M$0.021,214.75

Summary

Liquidia beats Warby Parker on 9 of the 17 factors compared between the two stocks.

How does Warby Parker compare to LivaNova?

Warby Parker (NYSE:WRBY) and LivaNova (NASDAQ:LIVN) are both mid-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Warby Parker has a beta of 1.96, meaning that its stock price is 96% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

Warby Parker has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$871.91M2.98$1.64M$0.021,214.75
LivaNova$1.39B2.82-$242.47M$1.9536.56

LivaNova has a net margin of 7.48% compared to Warby Parker's net margin of 0.15%. LivaNova's return on equity of 16.48% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker0.15% 2.30% 1.18%
LivaNova 7.48%16.48%7.59%

Warby Parker currently has a consensus target price of $29.50, suggesting a potential upside of 21.42%. LivaNova has a consensus target price of $79.38, suggesting a potential upside of 11.35%. Given Warby Parker's higher probable upside, analysts plainly believe Warby Parker is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.64
LivaNova
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Warby Parker had 1 more articles in the media than LivaNova. MarketBeat recorded 3 mentions for Warby Parker and 2 mentions for LivaNova. Warby Parker's average media sentiment score of 0.98 beat LivaNova's score of 0.58 indicating that Warby Parker is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.2% of Warby Parker shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 16.8% of Warby Parker shares are held by company insiders. Comparatively, 0.4% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Warby Parker beats LivaNova on 9 of the 16 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.69B$30.29B$15.89B$23.28B
Dividend YieldN/A3.49%3.55%4.06%
P/E Ratio1,215.3669.7625.5531.00
Price / Sales2.981.4947.5823.82
Price / Cash39.8834.5216.9624.93
Price / Book6.9810.305.504.67
Net Income$1.64M$1.33B$673.38M$1.07B
7 Day Performance-5.43%1.71%-1.22%-0.67%
1 Month Performance5.03%-0.86%-3.04%0.22%
1 Year Performance16.92%-18.79%-12.82%25.44%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
4.0922 of 5 stars
$24.30
-3.2%
$29.50
+21.4%
+16.7%$2.69B$871.91M1,215.364,036
GKOS
Glaukos
2.8705 of 5 stars
$103.41
+0.1%
$146.17
+41.3%
+17.1%$6.07B$507.44MN/A1,094
STVN
Stevanato Group
2.6114 of 5 stars
€18.86
-0.1%
N/A-14.0%€5.71B€1.34B31.976,010
BLCO
Bausch + Lomb
4.7379 of 5 stars
$15.37
-1.8%
$18.08
+17.7%
+30.7%$5.58B$5.10BN/A13,000
LQDA
Liquidia
2.4987 of 5 stars
$58.74
-5.0%
$50.88
-13.4%
+226.7%$5.50B$288.07M419.6050

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners